16 Apr CLEAR Response To The Daily Telegraph’s Reefer Madness

Daily Telegraph joint

Reefer madness is fighting back in the Daily Telegraph today with its ever-increasing Daily Mail tendencies sensationalising a study which looked at just 20 users of cannabis.

Even casual use of cannabis alters brain, warn scientists!

http://www.telegraph.co.uk/health/healthnews/10768847/Even-casual-use-of-cannabis-alters-brain-warn-scientists.html

‘Scientists’ could, of course (depending on where their funding comes from) claim that curry, sex, margaritas, running marathons or sky diving alters the brain. In fact, the evidence shows that cannabis is slightly less addictive and harmful than coffee. This has been shown time and time again by many studies over many years using very much larger sample sizes.

I refer to the Henningfield and Benowitz ratings of addictiveness, both of which show cannabis as less addictive than nicotine, heroin, cocaine, alcohol and caffeine: http://www.tfy.drugsense.org/tfy/addictvn.htm

In a world where Big Booze wields enormous power and corrupt influence, scientists are actively encouraged and funded to find any negative evidence they can about this beneficial plant.

These esoteric, bizarre conclusions divert common sense away from the simple truth that since the 1960s cannabis use has increased by many orders of magnitude yet all forms of mental illness are in decline while general intelligence, wellbeing and health are improving.

Reefer madness is as alive now as it was in the 1930s and those malevolent forces and vested interests that want to demonise cannabis are fighting a desperate rearguard action as the inevitable tide of legalisation sweeps the world.

For most adults, in moderation, cannabis is actually good for you. It is a natural supplement to our endocannabinoid system and helps to protect against autoimmune conditions such as diabetes and cancer. It is also neuroprotective and promotes neurogenesis which is why it is useful for the treatment of brain injury, stroke, Alzheimer’s and Parkinson’s. In fact, the US government holds a patent for the use of cannabinoids in the treatment of such conditions.